Evonik invites you to experience the future of pharmaceutical innovation at CPHI Frankfurt, taking place October 28–30, 2025 at Messe Frankfurt. For pharmaceutical innovators, CPHI is one of the best opportunities to learn about Evonik’s comprehensive portfolio designed to advance drug delivery, drug substance manufacturing, and biopharma development.
At booth #5.1A24, visitors can learn about:
- EUDRACAP® colon: Our functional capsules for oral drug delivery, now in GMP pre-launch phase, designed for targeted release in the colon.
- PhytoSquene®: An award-winning, plant-based squalene for parenteral drug delivery applications, offering a sustainable alternative to shark-derived sources.
- Advanced excipients: Lipids and bioabsorbable polymers tailored for injectable formulations.
- CDMO services: End-to-end support for drug substance manufacturing, from development to commercial scale.
- Biopharma solutions: Customized offerings to accelerate biologics development and production.
- And more…
Sustainability is at the heart of everything we do. Evonik’s commitment to green chemistry and responsible sourcing ensures that our innovations not only meet today’s pharmaceutical needs but also contribute to a healthier planet.
Whether you’re seeking new formulation strategies, reliable manufacturing partners, or sustainable solutions, Evonik’s experts are ready to collaborate and help you shape the future of health care.
Don’t miss the opportunity to connect with us at CPHI Frankfurt. Visit booth #5.1A24
